BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou X, Smith QR, Liu X. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1695. [PMID: 33470550 DOI: 10.1002/wnan.1695] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ribovski L, Hamelmann NM, Paulusse JMJ. Polymeric Nanoparticles Properties and Brain Delivery. Pharmaceutics 2021;13:2045. [PMID: 34959326 DOI: 10.3390/pharmaceutics13122045] [Reference Citation Analysis]
2 Wang Y, Sheng J, Chai J, Zhu C, Li X, Yang W, Cui R, Ge T. Filamentous Bacteriophage-A Powerful Carrier for Glioma Therapy. Front Immunol 2021;12:729336. [PMID: 34566987 DOI: 10.3389/fimmu.2021.729336] [Reference Citation Analysis]
3 Xu J, Yang X, Ji J, Gao Y, Qiu N, Xi Y, Liu A, Zhai G. RVG-functionalized reduction sensitive micelles for the effective accumulation of doxorubicin in brain. J Nanobiotechnology 2021;19:251. [PMID: 34419071 DOI: 10.1186/s12951-021-00997-z] [Reference Citation Analysis]
4 Zhou J, Li Q, Wu W, Zhang X, Zuo Z, Lu Y, Zhao H, Wang Z. Discovery of Novel Drug Candidates for Alzheimer’s Disease by Molecular Network Modeling. Front Aging Neurosci 2022;14:850217. [DOI: 10.3389/fnagi.2022.850217] [Reference Citation Analysis]
5 Wu L, Li Q, Deng J, Shen J, Xu W, Yang W, Chen B, Du Y, Zhang W, Ge F, Lei S, Li K, Wang Z. Platelet-Tumor Cell Hybrid Membrane-Camouflaged Nanoparticles for Enhancing Therapy Efficacy in Glioma. Int J Nanomedicine 2021;16:8433-46. [PMID: 35002237 DOI: 10.2147/IJN.S333279] [Reference Citation Analysis]
6 Upīte J, Brüning T, Möhle L, Brackhan M, Bascuñana P, Jansone B, Pahnke J. A New Tool for the Analysis of the Effect of Intracerebrally Injected Anti-Amyloid-β Compounds. J Alzheimers Dis 2021. [PMID: 34719500 DOI: 10.3233/JAD-215180] [Reference Citation Analysis]
7 Séguy L, Groo A, Malzert-fréon A. How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer’s disease treatment? Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.02.022] [Reference Citation Analysis]
8 Ren M, Wang Y, Luo Y, Yao X, Yang Z, Zhang P, Zhao W, Jiang D. Functionalized Nanoparticles in Prevention and Targeted Therapy of Viral Diseases With Neurotropism Properties, Special Insight on COVID-19. Front Microbiol 2021;12:767104. [PMID: 34867899 DOI: 10.3389/fmicb.2021.767104] [Reference Citation Analysis]
9 Putilina MV. [Asthenic disorders as a manifestation of chronic fatigue syndrome]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:125-30. [PMID: 34481448 DOI: 10.17116/jnevro2021121081125] [Reference Citation Analysis]
10 de Oliveira ECL, da Costa KS, Taube PS, Lima AH, Junior CDSDS. Biological Membrane-Penetrating Peptides: Computational Prediction and Applications. Front Cell Infect Microbiol 2022;12:838259. [DOI: 10.3389/fcimb.2022.838259] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Xu L, Xu S, Xiang T, Liu H, Chen L, Jiang B, Yao J, Zhu H, Hu R, Chen Z. Multifunctional building elements for the construction of peptide drug conjugates. Engineered Regeneration 2022. [DOI: 10.1016/j.engreg.2022.02.004] [Reference Citation Analysis]
12 Chen X, Zhang Q, Li B, Lu C, Yang S, Long J, He B, Chen H, Huang J. BBPpredict: A Web Service for Identifying Blood-Brain Barrier Penetrating Peptides. Front Genet 2022;13:845747. [PMID: 35656322 DOI: 10.3389/fgene.2022.845747] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Qiao L, Yang H, Shao X, Yin Q, Fu X, Wei Q. Research Progress on Nanoplatforms and Nanotherapeutic Strategies in Treating Glioma. Mol Pharmaceutics. [DOI: 10.1021/acs.molpharmaceut.1c00856] [Reference Citation Analysis]